Jiwei Liu

基本信息

浏览量：106

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 263 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Peripheral Inflammatory Factors As Prognostic Predictors for First-Line PD-1/PD-L1 Inhibitors in Advanced Non-Small Cell Lung Cancer

Chen-Xing Jin, Yan-Song Liu, He-Nan Qin, Yi-Bin Teng, Rui Sun, Zhong-Jing Ma, A-Man Wang,Ji-Wei Liu

Scientific reportsno. 1 (2025): 11206-11206

引用0浏览0WOSNATURE引用

Poor Prognosis of Early-Stage Acral Melanoma with a History of Trauma: a Multicenter Analysis of 468 Patients

Yi Teng, Jin Wu, Xin Cai,Weizhen Zhang,Kui Jiang,Hongfeng Zhou, Zhen Guo,Jiwei Liu, Yan Wang, Fang Liu,Shijie Lan,Hongxue Meng, Xiang Ji, Mei Xiang,Yongqi Li,Di Wu

The oncologistno. 5 (2025)

引用0浏览0WOS引用

Sugemalimab Versus Placebo, in Combination with Platinum-Based Chemotherapy, As First-Line Treatment of Metastatic Non-Small-cell Lung Cancer (GEMSTONE-302): 4-Year Outcomes from a Double-Blind, Randomised, Phase 3 Trial

Caicun Zhou,Ziping Wang,Meili Sun,Lejie Cao,Zhiyong Ma,Rong Wu,Yan Yu,Wenxiu Yao,Si Sun,Jianhua Chen,Wu Zhuang,Jiuwei Cui,Xueqin Chen,You Lu,Hong Shen,Chunhong Hu,Jiwei Liu,Yunpeng Liu,Mengzhao Wang,Xingya Li,Ping Sun,Yongqian Shu,Jianying Zhou,Jingzhang Li,Kangsheng Gu,Changli Wang,Hui Zhao,Yiping Zhang,Chunling Liu,Hui Yang,Xiaochun Zhang,Rui Ma,Lin Li,Li Liang, Man Li, Jingru Wang,Qiang Wang, Bo Wang, Hangjun Dai, Qingmei Shi,Jason Yang

The Lancet Oncology (2025)

引用0浏览0WOS引用

Cardiovascular Adverse Events Associated with EGFR and HER2 Dual TKIs: a Pharmacovigilance Study Based on the FAERS Database

Henan Qin, Yibin Teng, Peiyao Yu,Zhen Ning,Jiwei Liu

Expert opinion on drug safety（2025）

引用0浏览0WOS引用

Patient-reported Outcomes for the Phase 3 FURLONG Study of Furmonertinib Versus Gefitinib As First-Line Therapy for Chinese Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer

The Lancet Regional Health - Western Pacific (2024): 101122-101122

引用1浏览0WOS引用

Glycan-based Scaffolds and Nanoparticles As Drug Delivery System in Cancer Therapy

Henan Qin,Yibin Teng, Rui Dai,Aman Wang,Jiwei Liu

Frontiers in Immunology (2024)

引用1浏览0WOS引用

A Phase II Study of Efficacy and Safety of the MEK Inhibitor Tunlametinib in Patients with Advanced NRAS-mutant Melanoma

Xiaoting Wei,Zhengyun Zou, Weizhen Zhang,Meiyu Fang,Xiaoshi Zhang,Zhiguo Luo,Jing Chen,Gang Huang,Peng Zhang,Ying Cheng,Jiwei Liu,Jiyan Liu,Junping Zhang,Di Wu,Yu Chen, Xiaobiao Ma,Hongming Pan,Renbing Jiang,Xinlan Liu,Xiubao Ren,Hongqi Tian,Zhongwei Jia, Jun Guo,Lu Si

EUROPEAN JOURNAL OF CANCER (2024)

引用2浏览0WOS引用

Early-stage acral melanoma with a history of trauma associated with a poor prognosis:A multicenter data analysis of 468 cases

熠滕, Jin Wu,Xin Cai,Weizhen Zhang,Kui Jiang,Hongfeng Zhou,Zhen Guo,Jiwei Liu, Yan Wang, Fang Liu,Shijie Lan,Hongxue Meng, Xiang Ji, Mei Mei Xiang,Yongqi Li,Di Wu

crossref（2024）

引用0浏览0引用

Overall Survival and Efficacy Subgroup Analysis of Tunlametinib in Patients with Advanced NRAS-mutant Melanoma: A Multicenter, Open-Label, Single-Arm, Phase 2 Study

Xiaoting Wei,Zhengyun Zou,Weizhen Zhang,Meiyu Fang, Hang‐Seok Chang,Zhiguo Luo,Jing Chen,Gang Huang,Peng Zhang,Ying Cheng,Jiwei Liu,Jiyan Liu,Junping Zhang,Di Wu,Yu Chen, Xiaobiao Ma,Hongqi Tian, Zhaojun Jia,Jun Guo,Lu Si

Journal of Clinical Oncologyno. 16_suppl (2024): 9545-9545

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

助理教授

论文共 263 篇作者统计合作学者相似作者